Background: Non-small cell lung cancer (NSCLC) has a poor prognosis even for early
stages of the disease (stage I and II). We studied the prognostic value of PET FDG in …

Introduction The intensity of 18 F-fluorodeoxyglucose (18 F-FDG) uptake in positron
emission tomography could be of prognostic significance for patients with non-small cell …

Introduction Patients with stage I non–small-cell lung cancer (NSCLC) have a wide variation
in outcomes, most likely because there are undetected metastases at presentation. We …

Objective: To determine if the intensity of fluorine-18-fluorodeoxyglucose (FDG) uptake in
primary non-small cell lung cancer (NSCLC) could independently predict patient prognosis …

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer morbidity and
mortality. Adjuvant chemotherapy improves survival in resected early-stage NSCLC …

PURPOSE: Each pathological stage of non-small cell lung cancer (NSCLC) consists of a
heterogeneous population containing patients at much higher risk than others. Noninvasive …

The aim of the current study was to investigate the prognostic value of SUV (max) in patients
with completely resected early stage (stage I and II) NSCLC. A retrospective review …

PURPOSE: The amount of radio-labeled 18F-fluoro-2-deoxy-glucose (FDG) uptake, a
measurement of the increased glucose metabolism of non–small-cell lung cancer (NSCLC) …

Objective: Positron emission tomography (PET) is being increasingly used as an accurate
and non-invasive modality in diagnosis, staging and post-therapy assessment in patients …

Purpose: Because the tumor stage is the most significant prognostic factor for non-small cell
lung cancer (NSCLC) and given that NSCLC [18F] fluorodeoxyglucose (18F-FDG) uptake …